SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

CHENGDU, China, Sept. 28, 2023 /PRNewswire/ — Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”, SSE: 688222.SH) today announced that it has entered into a partnership with The Structural Genomics Consortium (“SGC”), a public-private partnership that supports the discovery of…